10月27日，三友医疗盘中上涨2.24%，截至13:26，报20.12元/股，成交4220.88万元，换手率0.68%，总 市值67.09亿元。 资金流向方面，主力资金净流入146.02万元，大单买入711.92万元，占比16.87%，卖出565.91万元，占 比13.41%。 机构持仓方面，截止2025年6月30日，三友医疗十大流通股东中，融通健康产业灵活配置混合A/B （000727）位居第五大流通股东，持股998.46万股，相比上期减少151.54万股。南方医药保健灵活配置 混合A（000452）位居第八大流通股东，持股672.14万股，相比上期增加16.46万股。 责任编辑：小浪快报 截至6月30日，三友医疗股东户数7108.00，较上期增加12.61%；人均流通股34954股，较上期减少 11.20%。2025年1月-6月，三友医疗实现营业收入2.50亿元，同比增长17.77%；归母净利润3660.08万 元，同比增长2083.64%。 分红方面，三友医疗A股上市后累计派现1.13亿元。近三年，累计派现3974.52万元。 三友医疗今年以来股价涨13.96%，近5个交易日涨1.82%，近20日涨2. ...

资料显示，上海三友医疗器械股份有限公司位于上海市嘉定区嘉定工业区汇荣路385号，成立日期2005 年4月19日，上市日期2020年4月9日，公司主营业务涉及医用骨科植入物和超声动力设备及耗材的研 发、生产与销售。主营业务收入构成为：脊柱植入物耗材63.80%，有源设备及配套辅件31.51%，创伤 植入物耗材3.53%，其他1.16%。 10月24日，三友医疗盘中上涨2.19%，截至09:49，报19.62元/股，成交890.22万元，换手率0.15%，总市 值65.43亿元。 资金流向方面，主力资金净流入22.47万元，大单买入22.47万元，占比2.52%，卖出0.00元，占比 0.00%。 三友医疗今年以来股价涨11.13%，近5个交易日涨1.03%，近20日跌2.00%，近60日涨5.48%。 分红方面，三友医疗A股上市后累计派现1.13亿元。近三年，累计派现3974.52万元。 机构持仓方面，截止2025年6月30日，三友医疗十大流通股东中，融通健康产业灵活配置混合A/B （000727）位居第五大流通股东，持股998.46万股，相比上期减少151.54万股。南方医药保健灵活配置 混合A（000452 ...

Core Viewpoint - Sanyou Medical has shown a mixed performance in stock price and financial metrics, with a notable increase in revenue and net profit year-on-year, indicating potential growth in the medical device sector [1][2]. Financial Performance - As of June 30, 2025, Sanyou Medical achieved a revenue of 250 million yuan, representing a year-on-year growth of 17.77% [2]. - The net profit attributable to shareholders reached 36.60 million yuan, marking a significant year-on-year increase of 2083.64% [2]. - The company has distributed a total of 113 million yuan in dividends since its A-share listing, with 39.75 million yuan distributed over the past three years [3]. Stock Performance - On September 22, 2023, Sanyou Medical's stock price increased by 2.15%, reaching 19.99 yuan per share, with a total market capitalization of 6.666 billion yuan [1]. - Year-to-date, the stock price has risen by 13.23%, while it has seen a slight decline of 0.05% over the last five trading days and a drop of 11.00% over the last 20 days [1]. - The stock has appreciated by 24.77% over the past 60 days [1]. Shareholder Information - As of June 30, 2025, the number of shareholders increased by 12.61% to 7,108, while the average number of circulating shares per person decreased by 11.20% to 34,954 shares [2]. - Among the top ten circulating shareholders, notable changes include a decrease of 1.5154 million shares held by Rongtong Health Industry Flexible Allocation Mixed A/B and an increase of 0.1646 million shares held by Southern Medicine Health Flexible Allocation Mixed A [3]. Business Overview - Sanyou Medical, established on April 19, 2005, and listed on April 9, 2020, specializes in the research, production, and sales of medical orthopedic implants and ultrasonic power devices and consumables [1]. - The company's main revenue sources include spinal implant consumables (63.80%), active devices and supporting accessories (31.51%), trauma implant consumables (3.53%), and others (1.16%) [1]. - The company operates within the pharmaceutical and biological industry, specifically in the medical device and consumables sector [1].

Company Overview - Sanyou Medical is located in Jiading District, Shanghai, and was established on April 19, 2005. The company went public on April 9, 2020. Its main business involves the research, development, production, and sales of medical orthopedic implants and ultrasonic power devices and consumables [1] - The revenue composition of Sanyou Medical includes: spinal implant consumables 63.80%, active devices and supporting accessories 31.51%, trauma implant consumables 3.53%, and others 1.16% [1] Financial Performance - As of June 30, 2025, Sanyou Medical achieved an operating income of 250 million yuan, representing a year-on-year growth of 17.77%. The net profit attributable to shareholders was 36.60 million yuan, showing a significant year-on-year increase of 2083.64% [2] - Since its A-share listing, Sanyou Medical has distributed a total of 113 million yuan in dividends, with 39.75 million yuan distributed over the past three years [3] Stock Performance - On September 17, Sanyou Medical's stock price decreased by 2.03%, trading at 19.82 yuan per share, with a total market capitalization of 6.609 billion yuan. The stock has increased by 12.26% year-to-date, but has seen a decline of 4.48% over the last five trading days and 4.62% over the last twenty days [1] - The stock's trading volume included a net inflow of 8.32 million yuan from main funds, with significant buying from large orders [1] Shareholder Information - As of June 30, 2025, the number of shareholders for Sanyou Medical was 7,108, an increase of 12.61% from the previous period. The average number of circulating shares per person was 34,954, a decrease of 11.20% [2] - Among the top ten circulating shareholders, the Rongtong Health Industry Flexible Allocation Mixed A/B fund held 9.98 million shares, a decrease of 1.52 million shares from the previous period, while the Southern Medicine Health Flexible Allocation Mixed A fund held 6.72 million shares, an increase of 164,600 shares [3]

资料显示，上海三友医疗器械股份有限公司位于上海市嘉定区嘉定工业区汇荣路385号，成立日期2005 年4月19日，上市日期2020年4月9日，公司主营业务涉及医用骨科植入物和超声动力设备及耗材的研 发、生产与销售。主营业务收入构成为：脊柱植入物耗材63.80%，有源设备及配套辅件31.51%，创伤 植入物耗材3.53%，其他1.16%。 截至发稿，王峥娇累计任职时间7年39天，现任基金资产总规模24.17亿元，任职期间最佳基金回报 70.35%， 任职期间最差基金回报-53.83%。 从基金十大重仓股角度 数据显示，南方基金旗下1只基金重仓三友医疗。南方医药保健灵活配置混合A（000452）二季度增持 16.46万股，持有股数672.14万股，占基金净值比例为5.35%，位居第五大重仓股。根据测算，今日浮盈 赚取约1055.26万元。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 从三友医疗十大流通股东角度 数据显示，南方基金旗下1只基金位居三友医疗十大流通股东。南方医药 ...